Yunnan White powder main product exposure Quality Door company said it has been recalled

December 20, the Sichuan Food and Drug Administration on its official website published in 2012, the second phase of drug testing of 36 unqualified batches of drugs, by the Luzhou Red Ridge Hospital monitoring Yunnan White Powder Capsules (20110213 batches of Specifications: 0.25G*16) was detected water unqualified. Reporter enquiries found that in the past 5 years, Yunnan white powder has many times because of drug quality, exaggerated advertising efficacy and other issues boarded many food and drug Supervision Bureau black List. 24th evening, Yunnan White powder issued a notice that the company has been involved in unqualified batches of products self-examination, a number of tests are in line with the standards, and that the batch of products caused by water is not eligible for transport, storage in the external physical or extreme environmental impact. Although Yunnan white Powder said in the announcement that the batch of products accounted for a small proportion of the company's sales, but it is noteworthy that this is the first time since 2007 Yunnan white powder detected unqualified products issued a notice. Although the main product frequency problem, but Yunnan white powder Three quarterly bulletin showed that the first three months of Yunnan white powder toothpaste income of 1.2 billion yuan, the year-on-year growth of about 40%. Repeatedly trapped in the "Quality Gate" Yunnan White Powder Three quarterly bulletin shows that the first three quarters to achieve operating income of 9.54 billion yuan, the growth of 23.3% in the same period, attributable to the listed company shareholder net profit of 1.123 billion yuan, increase 30.71%. With the increasing cost of the pharmaceutical industry, these figures are clearly enough to satisfy the market, but the phenomenon of Yunnan white powder products frequently on the black list of the Food and Drug Administration has forced the market to feel some concern. 2007 three, the Food and Drug Administration of Hubei Province issued a list of substandard drug quality, Yunnan white powder Group, "Tianqi Flower leaf Granules" (Lot 2004066), "Inspection of dry weightlessness" unqualified; "Hot Poison Clear film" (Compound lot number: 20050310), "character" unqualified. October 2008 Hebei Province Hejian Food and Drug Administration issued sampling unqualified drug bulletin, Yunnan white powder group Kunming Yun Jian Pharmaceutical Co., Ltd. "Erigeron tablets" (Lot: 20070470), "character" unqualified. In the three quarter of 2009, the Guangdong Provincial Food and Drug Administration released the "weight difference" unqualified situation in the "open chest and digestion tablets" (00309005 batches) of Yunnan white powder Group Lijiang Pharmaceutical Co., Ltd. July 2012, Yunnan white powder subsidiary Dali Pharmaceutical Co., Ltd. production of Qingfei Fire-suppression tablets (100726 lot number) will be due to the difference in weight by the Guangdong provincial Food and Drug Administration in the "black list." December 20, 2012, Sichuan Provincial Drug Administration on its official website published in 2012, the second phase of drug sampling 36 unqualified batches of drugs, which by the Luzhou Hospital monitoring Yunnan White Powder Capsules (20110213 batches of Specifications: 0.25G*16) was found to be unqualified water. In addition, Yunnan white powder is also suspected of false advertising propaganda. January 2008, the Beijing Municipal Drug Administration monitoring results showed that Yunnan white powder group Wuxi Pharmaceutical production of "Yunnan white drug can paste" is "unauthorized tampering with the contents of the examination and release of drug ads." "KuaLarge product indications, functional indications or contain unscientific expression of efficacy assertions, guarantees. "In the October 2009 illegal Drug advertising Bulletin, Liaoning Provincial Drug Administration of Yunnan white powder Group Wenshan Seven Flower Limited liability company," Qi Kang oral liquid "such a conclusion. Company: unqualified because the circulation link for Yunnan white powder capsule was detected water unqualified, Yunnan white powder in the evening of December 24 issued a notice to explain. It is also the first time since 2007 that the company has issued an announcement on such issues. The bulletin said that the company has organized relevant personnel on the sampling of unqualified batches of raw materials procurement, production, sales, circulation of the whole process of carding, audit, inspection, analysis and investigation. Including the production of the batch of products and inspection records for verification, production records show that the production process is carried out in accordance with the company's operating procedures, in line with the requirements of GMP management, factory product testing in line with quality standards; the samples of Yunnan white powder capsules were strictly tested, and the results met the standard requirements , the same batch of Yunnan white powder capsules were purchased from the market and tested strictly, the results also meet the standard requirements, the packaging design of the product and the history of the listing since the investigation, Yunnan white powder capsule packaging for a strong isolation effect of double-sided aluminum-plastic aluminum sealed packaging, no water unqualified quality problems. The company bulletin also said that, after comprehensive analysis, the batch of product moisture is very likely because of the circulation of transport, storage, custody process by the external physical or extreme environmental impact. In a responsible attitude towards consumers, the company has been recalled to the batch of products sent to the area. The batch of products produced a total of 199, involving the amount of 1.35 million yuan, the company accounted for a small proportion of sales revenue (the company 2011 Annual sales revenue of 11.3 billion yuan). Chongqing Drug exchange an analyst who declined to be named told the Daily Economic news reporter that the substandard product was the classic medicine for Yunnan white powder, Market share is larger, the reason why uncharacteristically issued a bulletin, is concerned about the impact of the classic drug market reputation. Yunnan White Powder 2012.5 Annual report shows that the first half of its operating income of 6.075 billion yuan, of which Yunnan white powder products and natural herbal products industrial sales income of 2.39 billion yuan, accounting for up to 39.34%. Its 2011 Annual report, 11.3 billion yuan of operating income, the main product for Yunnan white powder capsules, aerosol, Palace blood Ning, such as the "pharmaceutical Division" has contributed 2.135 billion yuan, accounting for up to 18.89%. In the above analyst opinion, Yunnan White powder in the announcement will be attributed to the "circulation link", it appears that some too urgent to evade responsibility, "the circulation of drugs will have a certain impact, but water evaporation is relatively rare." "The above analysts believe that Yunnan white powder in recent years the main product frequency problem with the" Cross-border "business has a certain relationship," pharmaceutical enterprises to develop a large health industry is a way of development, but should not give up its main business, should be extended from the main industry, can not afford to the end. "In response to the above query, Yunnan White powder director of the office responded that the announcement wasLord, do not respond too much.